Pharmacodynamics MBBS-Class 4.pptx

Embed Size (px)

Citation preview

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    1/31

    PharmacodynamicsDr.U.P.Rathnakar

    MD.DIH.PGDHM

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    2/31

    Adverse Drug Effects

    Any undesirable or unintended consequence of

    drug administration

    Any response to a drug that is noxious and

    unintended and that occurs at doses used in man

    for the prophylaxis, diagnosis, or therapy of

    disease or for modification of physiological

    function WHO

    Adverse event: Any untoward event that occurs

    during treatment not necessarily with causal

    relation ship to treatment

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    3/31

    Adverse Drug Reactions

    [ADR]

    Drugs used for favorable response

    Unfortunately also produce ADR

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    4/31

    ADR: Severity

    Minor:

    No tt required

    Moderate: Requires change in tt, change of drug

    Severe:

    Potentially life threatening, permanent damage Lethal:

    Directly or indirectly contributes to death

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    5/31

    ADR

    Type A[Augmented]

    Extension of

    pharmacological actions

    Predictable Dose dependent

    High incidence

    Low mortality

    Dose reduction

    Eg. Blurring of vision &

    dryness of mouth [atropine]

    Hypoglycemia[Glipizide]

    Type B [Bizarre]

    Immunological/genetic

    Not predictable

    Qualitative[not dose dependent]

    Low incidence

    High mortality

    Discontinue drug

    Eg. Anaphylaxis due to

    Penicillin , Hemolysis due to

    primaquine

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    6/31

    ADR

    Type A[augmented]

    Side effects:

    Unwanted ,unavoidable pharmacodynamic effects at

    therapeutic doses

    Eg. Antihistaminics cause sedation Secondary effects:

    Indirect consequence of primary action of a drug

    Eg. Tetracyclines cause super infection

    Toxic effects: Due to overdose or prolonged use

    Eg. Respiratory failure by morphine

    Coma by barbiturates

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    7/31

    ADR

    Type B[Bizarre]

    Allergy/hypersensitivity

    Idiosyncratic

    Type C[Continuous use]

    [dependence, organ

    toxicity]

    Type D[Delayed effect]

    Mutagenicity,

    carcinogenicity,

    teratogenic effect Type E[End of use]

    [withdrawal, HPA axis

    suppression]

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    8/31

    Intolerance

    Low threshold to the action of drug

    Eg. EPS with single dose of Metoclopromide

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    9/31

    Idiosyncrasy

    A genetically determined reaction

    An unusual individual reaction to food or a drug

    Eg. Barbiturates cause excitement and mental confusion

    Chloramphenicol causes aplastic anemia

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    10/31

    Drug allergy

    (drug hypersensitivity)

    Immunologically mediated reaction

    Types of drug allergy

    1. Anaphylactic- -Type I

    2. Cytolytic- -Type II

    3. Immune complex

    mediated[Arthus]: -Type III

    4. Delayed

    hypersensitivity -Type IV

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    11/31

    Type 1

    Eg. Betalactam antimicrobial agents

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    12/31

    Type 1

    [Anaphylactic]Exposure to

    drugEg.Penicillin

    IgE ABFixed tomast cells

    Re-exposure

    AG+AB

    Release of mediators:

    Histamine, 5-HT, PGs,LTs, PAF

    Anaphylactic shock:

    Hypotension,

    Bronchospasm, UrticariaEtc.

    Treatment:Medical emergency

    Inj.Adrenaline[1:1000]

    0.3 to 0.5 ml i.m.

    Inj.Hydrocortisone

    100 mgi.v.Inj.Diphenhydramine

    25mg i.v.

    Oxygen

    i.v. fluids

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    13/31

    Type II[Cytotoxic]

    Eg. Sulfa, thiazides, quinidinepuprura, hemolysis

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    14/31

    Type II [Cytolytic]

    Exposure to drug

    Eg.Quinine

    Drug+Tissue=AG

    IgG, IgM- ABRe exposure

    Tissue+AB

    Complement

    Cell destruction

    Eg. Hemolysis

    by Quinine,

    Quinidine

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    15/31

    Type III

    AG+ABIgG

    Complementfixation

    Destructive inflammatory response

    Eg. Serum sicknes [Fever,urticaria, joint pain,lymphadenopathy]

    Penicillin,

    SulfaNSAIDs

    Deposited on vascular

    endothelium

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    16/31

    Type IV[cell mediated, delayed]

    Eg.Contact dermatitis by metals, ointments

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    17/31

    Type IV [Delayed]

    Inflammatory responseDelayed by 2-3 days

    Not AB related

    Cell mediated

    Eg. Contact dermatitis with LA creams

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    18/31

    Photosensitivity[Pt. taking a drug develops reaction on body parts exposed to light]

    Phototoxicity [hyperpigmentation[desquamation]

    Sensitization of the skin by drugs

    UV radiation Cutaneous reaction-Photosensitivity

    Stopped when drug stopped

    Photo allergy [eczematous, papular]

    Persists even after drug withdrawal

    Examples????

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    19/31

    Carcinogenicity & mutagenicity

    Ability of the drug to cause cancer and genetic

    defects respectively

    Eg. Tobacco, anticancer drugs

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    20/31

    Iatrogenic diseases:

    iatros = physician

    (physician induced diseases):

    ParkinsonismPhenothiazines Peptic ulcer Aspirin,corticosteroids

    Hepatitis - Isoniazid

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    21/31

    Drugs frequently cause allergic

    reactions

    Penicillins

    Cephalosporin

    Sulfonamides

    Tetracyclines

    Quinolones

    Antitubercular drugs

    Salicylates

    Carbamazapine

    ACE inhibitors

    Local anesthetics

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    22/31

    Teratogenicity

    terataos = monster

    Capacity of the drug to cause fetal abnormalities when

    administered to pregnant mother

    I. Pre-implantation: conception to 17 days-Abortion

    ii.Organogenesis: 18-55 days-Deformities

    iii.Growth and development: 56 days onwards

    ThalidomidePhocomelia

    CorticosteroidsCleft lip

    TC- Discolouration of teeth, retarded bone growth

    PREGNANCY

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    23/31

    PREGNANCY

    CATEGORIES

    Category A [ANIMALS [-] Humans[-]-------------No riskStudies have failed to demonstrate a risk to the fetus

    Category B [ANIMALS [-] Humans[Not known] [ANIMALS [+] Human[none] ---No evidence

    of risk

    Animal reproduction studies have failed to demonstrate a risk to the fetus and there are

    no studies in pregnant women.

    Category C [ANIMALS [++] Humans[Not known] [Consider risk benefit before use]

    Animal reproduction studies have shown an adverse effect on the fetus and there are no

    adequate and well-controlled studies in humans, but potential benefits may warrant use of

    the drug in pregnant women despite potential risks.

    Category D [Humans risk ++] [Benefit may outweigh risk]There is positive evidence of human fetal risk - but potential benefits may warrant use of

    the drug in pregnant women despite potential risks.

    Category X [Abnormalities demonstrated] [Not to be used in pregnant women]

    Studies in animals or humans have demonstrated fetal abnormalities and/or there is

    positive evidence of human fetal risk based on adverse reaction data from investigational

    or marketing experience and the risks involved in use of the drug in pregnant womenclearly outweigh potential benefits.

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    24/31

    Organ toxicity

    Hepatotoxicity: INH, Rifampicin

    Nephrotoxicity: Aminoglycosides

    Ototoxicity: Aminoglycosides, Frusemide

    Ocular toxicity: Ethambutol, Chloroquine

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    25/31

    Drug dependence

    A state of

    Psychological or physical dependence

    Due to interaction - living organism+Drug

    Characterized by behavioral and other responses Always includes a compulsion to take the drug continuously or

    periodically

    Psychological: Intense desire to take drug and immensesatisfaction later

    Physical: Physiological equilibrium is maintained by drug

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    26/31

    Poisoning

    Poisons in small doses are the best medicines;

    and useful medicines in too large doses are

    poisonous

    William Withering 1789

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    27/31

    Poisoning

    Large enough dose of a drug

    Substance which endangers life

    Accidental or suicidal

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    28/31

    Poisoning

    Principles of treatment

    1.Resuscitation and maintenance of vital functions

    Airway, BP, Body temp., Blood sugar

    2. Termination of exposure

    Fresh air, remove wet clothes, wash,

    3. Prevention of absorption

    Gastric lavage, Activated charcoal,

    4. Hastening elimination

    Diuresis, Altering urine pH, Hemodialysis

    5. Antidotes if available

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    29/31

    Prevention of adverse effects

    Right dose, route, frequency

    Previous history drug allergy and allergic

    diseases

    Rule out drug interactions

    Correct technique of administration

    TDM if appropriate

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    30/31

    Clinical significance of ADR

    Common-

    3-5% of admissions

    Increases duration of

    stay

    Initially reversible

    Awareness-ADR or new

    symptoms

    Surgeries are avoided

    [gynecomastia andspironolactone]

    Reduce the no.of drugs

  • 7/27/2019 Pharmacodynamics MBBS-Class 4.pptx

    31/31

    Pharmacovigilance

    Actively look for adverse drug effects

    Activities relating to detection, assessment, understanding and prevention

    of adverse effects or any other drug related problem

    Causality assessment1. Temporal relationship

    2. Previous knowledge

    3. Dechallenge

    4. Rechallenge

    Information collected by

    Regional centers to

    Zonal centers to

    National centers to

    Uppsala monitoring center (Sweden)

    Definite, probable, possible or doubtful